Status:

COMPLETED

Ecopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label Extension

Lead Sponsor:

Emalex Biosciences Inc.

Conditions:

Tourette Syndrome in Children

Tourette Syndrome in Adolescence

Eligibility:

All Genders

6-18 years

Phase:

PHASE2

Brief Summary

This study was an international, multicenter, open-label, long term extension study evaluating the safety of ecopipam tablets for the treatment of children and adolescent subjects with Tourette Syndro...

Detailed Description

This was an international, multicenter, open-label, long term extension study to evaluate the safety of ecopipam tablets for the treatment of pediatric subjects (aged ≥6 to ≤18 years at Baseline) with...

Eligibility Criteria

Inclusion

  • Subjects must have completed the EBS-101-CL-001 study through the Day 14 Follow Up Visit within the last 30 days (or longer with permission of the medical monitor) without a major reportable protocol deviation and must be someone the Investigator feels would benefit from continued participation.

Exclusion

  • Certain mood or psychiatric disorders (i.e., dementia, bipolar disorder, schizophrenia, major depressive disorder).
  • Unstable medical illness or clinically significant lab abnormalities.
  • Risk of suicide.
  • Pregnant or lactating women.
  • Moderate to severe renal insufficiency.
  • Positive urine drug screen.
  • Certain medications that would lead to drug interactions.

Key Trial Info

Start Date :

October 4 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 11 2022

Estimated Enrollment :

124 Patients enrolled

Trial Details

Trial ID

NCT04114539

Start Date

October 4 2019

End Date

November 11 2022

Last Update

February 1 2024

Active Locations (65)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 17 (65 locations)

1

Harmonex Neuroscience Research

Dothan, Alabama, United States, 36303

2

Phoenix Children's Hospital

Phoenix, Arizona, United States, 85016

3

Advanced Research Center Inc.

Anaheim, California, United States, 92805

4

UCLA

Los Angeles, California, United States, 90095